Abeona Therapeutics
ABEO
ABEO
75 hedge funds and large institutions have $58.2M invested in Abeona Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more funds holding
Funds holding: 73 → 75 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.06% less ownership
Funds ownership: 1.32% → 1.26% (-0.06%)
Holders
75
Holding in Top 10
1
Calls
$556K
Puts
$371K
Top Buyers
| 1 | +$2.37M | |
| 2 | +$1.67M | |
| 3 | +$1.51M | |
| 4 |
Morgan Stanley
New York
|
+$656K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$595K |
Top Sellers
| 1 | -$5.07M | |
| 2 | -$1.52M | |
| 3 | -$1.51M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$528K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$404K |